Buckingham Research Downgrades Teva Pharma (TEVA) to Neutral
Tweet Send to a Friend
Buckingham Research downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
